Publications | Nephrology
Nephrology DIVISION OF NEPHROLOGY

      
Home Department of Medicine Educational Programs Sitemap Wednesday, May 22, 2013
Home | Print this page | Email this page to a friend |
Faculty
Clinics
Dialysis Unit
Research Projects
Education
Fellowship Program
Research Publications
nephrology current events and news
Forms & Schedules
nephrology and Critical Care Intranet
Directory
About Us
 
  Institutional Links:
  CCH Intranet Links
  Cook County Health &   Hospitals System
  John Stroger Hospital
  Department of Medicine
  Educational Programs
  Email Access:
  RUSH, CCHHS & CCHIL

  Division of Nephrology
  John Stroger Hospital
  Hektoen Building
  627 S. Wood St., Ste 639
  Chicago, IL 60612

Division of Nephrology Original Publications
Basic & Clinical 2000-2010
 
  1. Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O'Connor A, Perumal K, Rahman M, Steigerwalt S, Teal V, Townsend R, Weir M, Wright JT Jr; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010 Mar 55 (3):441-51.

  2. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010 Mar; 23(3):282-9.

  3. Patel J, Gudehithlu KP, Arruda JAL, Dunea G, Singh AK: Foreign body-induced granulation tissue is a source of adult stem cells. Translational Research 2010 (in print).

  4. Sam R, Khalid S, Brecklin C, Schwartz M, Dunea G: A Case of Lymphangioleiomyomatosis with Membranous Nephropathy and Likely Systemic Lupus,Clin Exper Nephrol. 2010, in print.

  5. Reilly B;M, Hart PD, Mascarell S, Chatrath H. Clinical problem solving: A question well put. N Engl J Med 2009; 360:1446-51.

  6. Shrishimal K, Hart PD, Michota F, Managing diabetes in hemodialysis patients: observations and recommendations Cleveland clinic journal of medicine 2009; 76:649-655.

  7. DeLoach SS, Appel LJ, Chen J, Joffe MM, Gadegbeku CA, Mohler ER 3rd, Parsa A, Perumal K, Rafey MA, Steigerwalt SP, Teal V, Townsend RR, Rosas SE. Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency Cohort. Am J Hypertens. 2009 Dec;22(12):1235-41.

  8. Singh AK, Pancholi N, Patel J, Litbarg NO, Gudelithu KP, Sethupathy P, KrausM, Dunea G, Arruda JAL:. Omentum facilitates liver regeneration. World Journal of Gastroenterology, 2009; 15: 9:1057.

  9. Singh AK, Gudelithu KP, Sethupathy P, Sam R, Gaffari A, Arruda JAL, Dunea G: Determination of carbamylated hemoglobin by an enzyme immunoassay (ELISA) based novel antibody. Clinica Chemica Acta 2008; 391:112-114.

  10. Singh AK, Patel J, Litbarg NO, Gudelithu KP, Sethupathy P, Arruda JAL, Dunea G: Stromal cells cultured from omentum express pluripotent markers, produce high amonts of VEGF,and engraft to injured sites. Cell Tissue Research 2008; 332:81-88.

  11. Hart P, Bakris GL. Calcium Antagonists: Do they equally protect against kidney injury? Kidney International 2008; 73:795-6.

  12. Hart P (The On target Investigators*: Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547-59.

  13. Hart P (Transcend Investigators)*: Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant of angiotensin-converting enzyme inhibitors: a randomized controlled trial. Lancet 2008; 372: 1174-1183.

  14. Joshi A, Ing T: Failure of sonography to visualize a kidney affected by Emphysemaotus Pyelonephritis. Indian Journal of Urology. 2007; 23 (2): 200-202.

  15. Joshi A, Levine J: Angiotensin-Converting Enzyme Inhibition and Chronic Kidney Disease: Does Proteinuria Matter? Kidney: A Current Survey of World Literature. 2007; 16(5), 204-208.

  16. Yadav SS, Brecklin C. “Asymmetric Dimethylarginine: The Missing Link between Chronic Kidney Disease and Cardiovascular Mortality? Kidney: A Current Survey of World Literature 2007; 6:4-7.

  17. Singh AK, Gudelithu KP, Patri S, Litbarg NO, Sethupathy P, Arruda JAL, Dunea G. Impaired integration of epithelial progenitor cells in capillaries of diabetic wounds is reversible with VEGF infusion. Translational Research 2007; 149:282.

  18. Hart P, Bakris GL. Should Beta Blockers be used to control hypertension in people with chronic kidney disease? Seminars in Nephrology 2007; 27:555-564.

  19. Hart P, Vaseemudin M, Egiebor O, Dunea G. Bilateral Emphysematous pyelonephritis in a patient with no known risk factors: case report and review of current literature. J Natl Med Assoc 2007; 99:179-181.

  20. Litbarg NO, Gudelithu KP, Sethupathy P, Arruda JAL, Dunea G, Singh AK. Activated omentum becomes rich in factors that promote healing and tissue regeneration. Cell Tissue Res 2007; 328:487-497.

  21. Kalyani Perumal, Amishi Patel, James P. Lash. Automatic reporting of Estimated GFR: Is it ready for prime time? Kidney: A Current Survey of World Literature 2007; 16:102-106.

  22. Singh AK, Gudelithu KP, Litbarg NO, Sethupathy P, Arruda JAL, Dunea G. Transplanting fragments of diabetic pancreas into activated omentum gives rise to new insulin producing cells. BBRC 2007; 355:258.

  23. Hart PD, Vaseemudin M, Egiebor O, and Dunea G. Bilateral emphysematous pyelonephritis in a patient with no risk factors. J Nat Medical Assoc 2007; 99:1.

  24. Joshi A, Sam R, Prasad R: Acute renal failure due to Metformin overdose. Kidney: A Current Survey of World Literature 2006: 15(1) :1-4.

  25. Sam R, Wanna L, Gudehithlu KP, Garber SL, , Dunea G, Arruda JAL, Singh AK. Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-ß reverses transformation. Translational Research 2006, 48:142.

  26. Hart PD, Bakris GL. Targeting Albuminuria for cardio-renal protection in diabetic and hypertensive renal disease. Kidney 2006:15:149-154.

  27. Bakris GL, Hart P, Ritz E. Beta blockers in the management of chronic kidney disease. Kidney International 2006; 70:1905-1913.

  28. Kraus, MA. Peripheral arterial occlusive disease and its medical management in patients with kidney disease. Kidney; A Current Survey of World Literature 2006.

  29. Julio C.Vijil, Jr, Kalyani Perumal, Jennifer S.Shroff, Eric R. Taylor, Raymond R. Townsend, James P. Lash Arterial Stiffness in Patients with Kidney Disease-An Update. Kidney: A Current Survey of World Literature 2006; 15:101-105.

  30. Vaseemuddin, M, Schwartz, MM, Dunea, G, KrausMA. Idiopathic hypocomplementemic immune complex mediated tubulo-interstitialnephritis: Nature Clinical Practice Nephrology 2006; 3:50.

  31. Sam R, Wu H, Yue L, Mazzone T, Schwartz MM, Arruda JAL, Dunea G, Singh AK. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding. Am J Kid Dis 2006; 47:532.

  32. Hart PD, Bakris GL. Management of hypertension in patients with the metabolic syndrome. Family practice recertification journal 2005; 11:1-9.

  33. Prasad R, Perumal K, Fischer MJ:. Chronic Kidney Disease and Pregnancy-An Update. Kidney: A Current Survey of World Literature 2005; 14:101-105.

  34. Kalyani Perumal, Michael J.Fischer, Robert Mrtek. Efficacy of Furosemide in ARF : Letter to the Editor. American Journal of Kidney diseases 2005; 45(4):786.

  35. Gudelithu KP, Ahmed N, Wu H, Litbarg NO, Garber S, Arruda JAL, Dunea G, Singh AK. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue Lab Clin Med 2005; 145:194.

  36. Khosla N, Hart PD, Bakris GL. Management of Hypertension in the cardiometabolic syndrome and diabetes. Curr Diab Rep 2004; 4:199-205.

  37. Hart PD. Maximum reduction of proteinuria in renal disease: is there a role for combining angiotensin-converting enzyme inhibitors with angiotensin receptor blockers? Kidney 2004; 13:99-103.

  38. Khodakov, Kalyani Perumal,Louis G. Rohr, Joseph A. Akamah, Tunji M. Alausa, Christopher A. Smith, Jeremy P. Smith The Impact of Evidence on Physician’s Inpatient Treatment Decisions. JGIM 2004; 19:492-495.

  39. Hart PD, Bakris GL. Hypertension control rates: It’s time for translation of guidelines into clinical practice. Editorial. Am J Med 2004; 117:62-4.

  40. Singh AK, Gudelithu KP, Le G, Litbarg, N, Khalili V, Vernik J, Hart P, Arruda JAL, Dunea G. Decreased urinary peptide excretion in patients with renal disease. Am J Kidney Dis, 2004; 44:1031.

  41. Gudelithu KP, Pegoraro AA, Dunea G, Arruda JAL, Singh AK. Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int 2004; 65:2133.

  42. Kraus, MA, Recent progress in HIV-associated nephropathy: a discussion pertinent to clinical practice. Int J Artif Organs. 2004; Nov;27(11):913-7.

  43. Singh AK, Gudehithlu KP, Pegoraro AA, Singh GK, Basheerudin K, Robey RB, Arruda JAL, Dunea G. Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Lab Invest 2004; 84:597-606.

  44. Tao LT, Hart PD, et al: Treatment of difficult-to-control blood pressure in a multi-disciplinary clinic at a public hospital. J Natl Med Assoc 2003; 95:263-269.

  45. Sam R,Shaykh MS, Pegoraro AA, Khalili V, Hristea I, Singh AK, Arruda JAL, Dunea G. The significance of trace proteinuria. Am J Nephrol 2003; 23:438-441.

  46. Garber SL, Mironchnik MS, Brecklin C, Slobodskoy L, Arruda LJ, Dunea G. Effect of relaxin on two models of renal mass reduction. Am J Nephrol 2003; 23:8.

  47. Kraus, M.A. and Lash, J.P. Critical Appraisal of Primary Clinical Studies: Part I. Kidney; A Current Survey of World Literature, 2002.

  48. Kraus, M.A. and Lash, J.P. Critical Appraisal of Primary Clinical Studies: Part 2. Kidney; A Current Survey of World Literature, 2002.

  49. Pegoraro AA, Gudelithu KP, Cabrera E, Shankar R, Arruda JAL, Dunea G, Singh AK. Handling of low-density lipoprotein by the renal tubule:Release of fragments due to incomplete degradation. J Lab Clin Med 2002; 139:372.

  50. Brecklin CS, Garber SL. “Primer of Urinalysis III: Proteinuria Promises and Pitfalls”. Kidney: A Current Survey of World Literature 2002; 11:95-97.

  51. Garber SL, Mironchnik Y, Arruda JAL, Dunea G, Slobodoskoy L. Differential effects of enalapril and ibersartan in experimental papillary necrosis. Kidney Blood Pressure Research, 2001; 24:39-43.

  52. Dunea G. Dialysis Dementia. An epidemic that came and went. ASAIO Journal. 2001; 47:192-194.

  53. Bakir AA, Dunea G. Renal disease in the inner city. Seminars in Nephrology 2001;21:334-345.

  54. Garber SL, Mironchnik MS, Brecklin C, Unemori EN Singh AK, Slobodskoy L,Grove BH, Arruda JAL, Dunea G. Relaxin decreases renal interstitial fibrosis and slows the progression of renal disease. Kidney Int. 2001; 59:876-882.

  55. Garber SL, Mironchik Y, Arruda AL, Dunea G . Differential effect of enalapril and irbersartan in experimental papillary necrosis. Kidney and Blood Pressure Research. 2001; 24:39.

  56. Garber SL, Mironchnik MS, Brecklin C, Unemori EN Singh AK, Slobodskoy L,Grove BH, Arruda JAL, Dunea G. Relaxin decreases renal interstitial fibrosis and slows the progression of renal disease. Kidney Int. 2001; 59:876-882.

  57. Brecklin CS, Garber SL. “Primer of Urinalysis: I. Macroscopic Exam and Reagent Strip Analysis”. Kidney: A Current Survey of World Literature 2001; 10:95-98.

  58. Garber SL, Mironchnik MS, Brecklin C, Slobodskoy L Unemori EN, ,Grove BH, Arruda JAL. Dunea G. Relaxin decreases renal interstitial fibrosis: A nove treatment to slow the progression of kidney disese? Proc 3rd International conference on relaxin and related Peptides, 22-27 Oct 2000, Broome , Ausrtalia.

  59. Pegoraro AA, Singh AK, Arruda JAL, Dunea G, Bakir AA. A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome. Kidney Int 2000; 58:1342-1345.

  60. Pegoraro AA, Peracha W, Hasnain M, Rangiwala N, Shaykh M, Singh AK, Arruda JAL, Dunea G. Evaluation of a new method to measure urinary albumin in lieu of urinary total protein. Amer J Kidney Dis 2000; 35:739-744.

  61. Kraus, M.A. and Kornetsky, C. Cue-induced changes in basal local cerebral glucose utilization 13 days after morphine sensitization in the Fischer 344 rats: relevance for drug craving. Brain Research 2000; 865:194-201.

BOOK CHAPTERS

  1. Hart PD, Bakris GL. Hypertension and the Kidney, IN: Hans Brunner (ed) Year in Hypertension. Clinical publishing. Oxford. 2006, vol 6, chapter 5, pp 57-72.

  2. Leehey DJ, Singh AK, Singh R. Angiotensin II and its receptors in the pathogenesis of diabetic nephropathy. In Angiotensin and its receptors in renal physiology and pathology (Eds Cortez, Riser). Academic Press. 2005. New York NY. Hart PD, Bakris GL. Management of hypertension in patients with the metabolic syndrome. Family practice recertification journal 2005.

  3. Hart PD, Bakris GL. Managing Hypertension in diabetic patients. IN: Egan BM, Basile JN, Lackland DT (eds.) Hot Topics in Hypertension. Hanley and Belfus, inc. Pennsylvania. 2004, Chapter 25, pp 249-262.

  4. Hart PD, Bakris GL. Combination therapy for hypertension and renal disease in diabetes. IN: Mogensen CE (ed.) The Kidney and Hypertension in Diabetes Mellitus. Sixth edition. Taylor & Francis. London 2004, Chapter 40, pp 767-784.

  5. Hart PD, Bakris GL. Treatment of diabetic hypertension: goals and choices. IN: Kaplan NM (ed.) Hypertension Therapy Annual 2002 Dunitz & Co. London, 2002, Chapter 3, pp 41-54.

  6. Kevin A, Hart PD, Bakris GL. Treatment strategies for the Diabetic patient with Hypertension. Hypertension and Diabetes 2002. Mogensen CE (ed.) Lippincott Williams & Wilkins. London. Vol.1, Chapter 2, pp13-28.

  7. Zoccali C and Dunea G. Hypertension. In Handbook of Dialysis, by John Daurigas, T Ing, Little, Brown and Company, Third Edition, 2001.

  8. Dunea,G Co-editor of The Oxford Illustrated Medical Companion with Stephen Lock and John Last - and author of sections on Noise; Hypertension; Executions; Grand Rounds; and Violence, 2001.

 
 
Home | Contact us | Privacy policy | Terms of use | Site Map

Copyright ©1998-2013 John Stroger Hospital. All rights reserved.
All information is not a substitute for medical advice or treatment for specific medical conditions.
If you have any health-care related questions or suspect you have a health problem, you should consult your health-care provider.